PUBLISHER: iData Research Inc. | PRODUCT CODE: 1680160
PUBLISHER: iData Research Inc. | PRODUCT CODE: 1680160
The global robotic radiosurgery system market was valued at $350 million in 2024 and is projected to grow at a CAGR of 11.1%, reaching $720 million by 2031.
The market is segmented into:
Market Insights & Data Coverage
Market Trends & Growth Drivers
* Global cancer cases are rising due to:
* Population growth & aging
* Lifestyle factors (smoking, alcohol, poor nutrition, obesity, stress)
* WHO projects over 35 million new cancer cases, a 77% increase from 2022.
* Radiation therapy contributes 40% to curative cancer treatments, but global utilization remains under 50%, indicating room for growth.
Challenges & Market Limitations
Geographic Trends & Growth Projections
Market Share Insights
Leading Competitors & Key Developments
1 Accuray - Market Leader
* Offers CyberKnife(R), a leading robotic radiosurgery system.
* Partnership with Brainlab (2020) expanded CyberKnife(R)'s neuro-radiosurgery applications.
* Partnership with Limbus AI Inc. (2022) aimed at integrating AI-powered radiation therapy solutions.
2 Zap Surgical - Emerging Competitor
* Zap-X(R) Gyroscopic Radiosurgery(R) system is an innovative, self-shielded radiotherapy device.
* Focuses on treating brain, head, and neck conditions.
* More affordable than CyberKnife(R), with an estimated price below $2 million.
Market Segmentation Summary
Global Research Scope
* North America (U.S., Canada)
* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)
* Western Europe (Germany, France, U.K., Spain, Italy)
* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)
* Middle East (Saudi Arabia, UAE, Israel)
* Asia-Pacific (China, Japan, India, South Korea, Australia)
* Africa (South Africa, Egypt, Nigeria, Kenya)
Quantitative Coverage
Qualitative Coverage
Data Sources